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Small for gestational age (SGA) neonates are deﬁned as neo-
nates with a birth weight below the 10th percentile of the
growth curve for a given gestational age (GA). In the
Netherlands annually approximately 18,000 neonates are
born SGA, the majority at term.1,2 This is a heterogeneous
group comprising neonates that are constitutionally small
and neonates that have failed to achieve their growth poten-
tial because they are growth restricted based on uteropla-
cental insufﬁciency, congenital anomalies, or infection.3–5
SGA is associated with an increased risk of adverse pregnancy
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Abstract Objective To assess differences in mode of delivery and pregnancy outcome between
prenatally detected and nonprenatally detected small for gestational age (SGA) neo-
nates born at term.
Study Design We performed a retrospective multicenter cohort study. All singleton
infants, born SGA in cephalic position between 360/7 and 410/7 weeks gestation, were
classiﬁed as either prenatally detected SGA or nonprenatally detected SGA. With
propensity scorematching we created groups with comparable baseline characteristics.
We compared these groups for composite adverse perinatal outcome, labor induction,
and cesarean section rates.
Results We included 718 SGA infants, of whom 555 (77%) were not prenatally
detected. Composite adverse neonatal outcome did not differ statistically signiﬁcant
between the matched prenatally detected and the nonprenatally detected group (5.5
vs. 7.4%, odds ratio [OR] 0.74, 95% conﬁdence interval [CI]: 0.30–1.8). However,
perinatal mortality only occurred in the nonprenatally detected group (1.8% [3/163] in
the matched cohort, 1.3% [7/555] in the complete cohort). In the propensity matched
prenatally detected SGA group both induction of labor (57 vs. 9%, OR 14.0, 95% CI: 7.4–
26.2) and cesarean sections (20 vs. 8%, OR 2.9, 95% CI: 1.5–5.8) were more often
performed compared with the nonprenatally detected SGA group.
Conclusion Prenatal SGA detection at term allows timely induction of labor and
cesarean sections thus potentially preventing stillbirth.
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outcome and adverse events in the postpartum phase.6–9 The
more pronounced the SGA, the higher the risk of antepartum
death.10
It is assumed that early detection of SGA could improve
fetal outcome by close fetal monitoring and the possibility for
timely induction of labor or instrumental deliverywhen fetal
condition seems compromised.11 At present, no effective
intervention is available to improve the outcome of SGA
infants at term.6Ohel et al and Verlijsdonk et al both assessed
differences in management of labor and perinatal outcome
between prenatally detected SGA and nonprenatally
detected SGA at term.12,13 While both studies showed
more labor inductions and cesarean sections in the prenatal-
ly detected SGA group, pregnancy outcome differed between
the two studies. Ohel et al showed a higher rate of adverse
neonatal outcome in prenatally detected SGA,12 whereas
Verlijsdonk et al concluded that prenatal suspected SGA
was associatedwith lower rates of adverse neonatal outcome
compared with nonprenatally detected SGA (3.8 vs. 9.0%,
p ¼ 0.056).13 Both studies were small and likely biased by
confounding, as the results were not adjusted for severity of
growth restriction. This resulted in comparison of more
severely growth restricted—prenatally detected—infants to
generally milder SGA infants that were detected after birth.
The actual impact of the prenatal detection of SGA remains
uncertain.
The aim of this study was to assess, in groups with a
comparable possibility of prenatal SGA detection, whether
prenatal SGA detection in term infants improves perinatal
outcome and whether this detection inﬂuences the timing
and mode of delivery.
Materials and Methods
Study Design
We conducted a retrospective cohort study of women with a
singleton SGA child born at home or in the hospital between
360/7 and 410/7 weeks of gestation, between 1 April, 2005 and
31 December, 2008. We classiﬁed infants as being prenatally
detected SGA and nonprenatally detected SGA. Classiﬁcation
of prenatal SGA detection was based on ultrasonographically
measured abdominal circumference < p10, estimated fetal
weight < p10, ﬂattening of the growth curve in the third
trimester (as judged bya clinician), or the presence of all three
factors. Subsequently, we created comparable groups of
prenatally detected SGA and nonprenatally detected SGA
infants by propensity score matching and compared preg-
nancy outcome and mode of delivery between these two
groups.
Inclusion and Exclusion Criteria
We included pregnant women  18 years with a singleton
pregnancy who gave birth to SGA neonates at a GA between
360/7 and 410/7 weeks in the catchment area of one of the
following two hospitals and seven midwifery practices: the
AcademicMedical Center in Amsterdam, theMaximaMedical
Center in Veldhoven, or one of the seven independent mid-
wifery practices referring to these two medical centers.
To warrant comparability of pregnancies with an prena-
tally detected SGA and nonprenatally detected SGA infants,
we excluded women with a breech presentation at birth,
women with a child with fetal structural or chromosomal
anomalies, women with a previous cesarean section, and
women with pregnancies with uncertainty about duration
of pregnancy.
SGAwas deﬁned as a birth weight below the 10th percen-
tile for GA.14 The Dutch reference curves for birth weight by
GA stratiﬁed for parity, sex, and ethnic backgroundwere used
to calculate birth weight percentiles on a continuous scale for
all infants.14 Pregnancy dating was performed by last men-
strual period, or ultrasound measurements before 20 weeks
of gestation (crown-rump-length or head-circumference
measurement).
Data Collection
We searched the perinatal databases from the two participat-
ing hospitals and seven midwifery practices, to identify
pregnancies with an prenatally detected SGA infant. Prena-
tally detected SGA infants had previously been eligible for
inclusion in the DIGITAT (the Disproportionate Intrauterine
Growth Intervention Trial At Term) study, an randomized
equivalence trail that was performed to compare the effect of
induction of labor with a policy of expectant monitoring for
intrauterine growth restriction near term.6Weused the same
GA criteria as in the DIGITAT study to avoid loss of cases
through a cut off at term (370/7 weeks gestation) instead of
360/7weeks gestation. To ensure inclusion of all nonprenatally
detected SGA infants in the study period, we used the
Netherlands Perinatal Registry (PRN), to complement data
that could not be retrieved from themedical ﬁles. The PRN is a
national database that contains linked maternal and neonatal
data entered bymidwives, gynecologists, and pediatricians.15
It contains information on 96% of all pregnancies, home and
hospital births, and readmissions until 28 days after birth. It
does not contain information on whether SGA is detected
prenatally.16 We collected information on maternal charac-
teristics: body mass index (BMI), smoking, parity, gestational
hypertension; delivery characteristics: start of labor, mode of
delivery, GA at delivery; and neonatal characteristics: Apgar
score, birth weight, sex, neonatal complications, intrauterine
fetal death, and neonatal death.
Outcome Measures
Outcomes of this study were adverse perinatal outcomes,
intrauterine fetal death, neonatal death, neonatal complica-
tions, and a composite of these adverse outcomes. We also
assessedwhether therewere differences in induction of labor
and instrumental delivery rates between both the groups.
Intrauterine fetal death was deﬁned as spontaneous fetal
demise between 360/7 and 410/7weeks gestation and neonatal
death was deﬁned as a live birth resulting in infant death
within 28 days of life. Neonatal complicationswere deﬁned as
5 minute Apgar score < 7, asphyxia, infant respiratory dis-
tress syndrome, meconium aspiration, pneumothorax or
pneumomediastinum, necrotizing enterocolitis, convulsions,
sepsis, and meningitis. Instrumental delivery was divided
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into primary cesarean section, cesarean section in labor, and
instrumental vaginal delivery.
Analysis
We used propensity score matched-pairs analyses to deter-
mine the association between prenatal SGA detection and the
primary and secondary outcomes, while balancing potential-
ly important confounders between both the groups. The
rationale and methods underlying the use of propensity
scores for proposed causal exposure variables have been
previously described.17,18
The propensity scores were generated by logistic regres-
sion, based on all covariates that were known to be associated
with perinatal outcome and that existed before the start of
labor. We considered the continuous covariates maternal age,
maternal BMI, and birth weight percentile as well as the
dichotomous covariates primiparity, maternal smoking, ges-
tational hypertension, birth weight < p2.3, and birth weight
< p5. Since propensity scores cannot be calculated if one of
the variables ismissing, single imputationwas used to replace
missing values.19
The standardized differencewas used to assess the balance
of the covariates, as unlike signiﬁcance testing it is not
dependent of the size of the sample.17 A standardized differ-
ence greater than 10% points was used to indicate that the
samples were meaningfully different.20 After generation of
propensity scores, pairs were matched on their propensity
score, using one-to-one nearest neighbor matching without
replacement.21–25 We matched nonprenatally detected SGA
infants to the smallest group (prenatally detected SGA), to
ensure that as many matches as possible could be made.
To compare baseline and pregnancy characteristics of
prenatally and not prenatally detected SGA pregnancies we
used Student’s t-tests, χ2 tests, and Fisher exact tests. In the
matched cohort, the standardized difference was used to
assess the balance of the covariates of the propensity scores.
We also assessed the baseline characteristics of both groups
to ensure that matching increased comparability.
To compare outcomes between prenatally detected and
not detected SGA infants, odds ratios (ORs) with 95% conﬁ-
dence intervals (CIs) were computed for all dichotomous
outcomes using logistic regression. Mean differences and
95% CIs were calculated for continuous variables with the
independent t-test for normally distributed data. The Mann-
Whitney U test was used to assess differences in continuous
variables that were not normally distributed.
In a sensitivity analysis, we performed the analyses on a
propensity score matched cohort of the original (nonim-
puted) dataset. We also used multivariable logistic regression
analysis in the original dataset to determine the adjusted
association of prenatally detected SGAwith adverse outcome
and mode of delivery in the entire sample.
Statistical analyses were conductedwith SPSS version 19.0
for Windows (IBM Corporation, Armonk, NY). Propensity
score calculation and matching were performed in R with
the SPSS R-plugin.25 The following R packages were invoked:
MatchIt,23,24 RItools,22 and CEM.26 A two-tailed p-value
< 0.05 was considered statistically signiﬁcant.
Results
In the study period, 11,142 women delivered in one of the
selected centers.►Fig. 1 displays all our exclusions to arrive at
a ﬁnal cohort of 718 SGA infants.►Table 1 shows the baseline
pregnancy characteristics for prenatally detected SGA and
nonprenatally detected SGA pregnancies in the unmatched
cohort. The majority of SGA infants, 77% (555/718) remained
undetected until after birth.
Characteristics of the prenatally detected SGA group and
the nonprenatally detected SGA group are presented
in ►Table 1. In the prenatally detected SGA group 51% of
infants were < p2.3 versus 21% in the nonprenatally detected
SGA group. Smoking and primiparity were more prevalent in
the prenatally detected SGA group (OR 2.8, 95% CI 1.9–4.2 and
OR 1.6, 95% CI 1.2–2.4, respectively).
We know of 234 women in the cohort that they were
referred for ultrasound growth assessment in the third tri-
mester of pregnancy. A total of 19% (45/234) of these women
were reassured about fetal growth but gave birth to a SGA
infant. Because SGA was no longer suspected after the ultra-
sound, infants delivered by these women are classiﬁed as
nonprenatally detected SGA infants.
Five of the six predeﬁned baseline variables used for
propensity score matching contained no missing data because
these variables were required ﬁelds that caregivers are used to
register. The sixth variable BMI lacked in 44% (316/718) of the
women. Distribution plots of propensity scores in the two
groups are shown in►Fig. 2. Overall, as a function of baseline
characteristics, the prenatally detected SGAgrouphad a higher
probability of prenatal SGA detection, as indicated by a higher
mean propensity score (0.315  0.156 vs. 0.201  0.127;
p < 0.001). The initial difference in the two groupswas further
supported by the standardized difference criterion, which
revealed that six of the eight baseline covariates (75%) had a
standardized difference of > 10% and therefore were imbal-
anced by this criterion. The identiﬁed differences and the
inherent selection bias they represent, supported the need
for further adjustment with propensity matching. This match-
ing process resulted in the creation of 163 matched prenatally
detected SGA and nonprenatally detected SGA pairs.
►Fig. 2 displays the distributions of the two matched
groups’ propensity scores. In contrast to the distributions of
the unmatched groups, it reveals a high degree of overlap and
similarity of shape between the two groups. This improved
covariate balancewas also reﬂected as the reduced difference
in the means of the propensity scores reduced from 0.114
before matching, to 0.004 after matching (0.315  0.156 in
the prenatally detected SGA group and 0.311  0.150 in the
nonprenatally detected SGA group; p ¼ 0.80). The standard-
ized difference criterion analysis conﬁrmed the groups’ sim-
ilarity, as the highest standardized difference was 7.9%,
where < 10% is deemed acceptable (►Table 2).
The distribution of the outcomes in the matched pairs of
prenatally detected SGA and nonprenatally detected SGA is
presented in ►Table 3. Composite adverse neonatal outcome
occurred in 5.5% (9/163) of infants in the prenatally detected
SGA group and 7.4% (12/163) in the nonprenatally detected
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SGA group (OR 0.74, 95% CI 0.30–1.8). Perinatal death oc-
curred in none of the 163 prenatally detected SGA neonates
and in 3 (1.8%) of the 163 nonprenatally detected SGA neo-
nates (OR not calculable, p ¼ 0.996). Birth weights of these
three infants were below the ﬁrst percentile. The cohort was
too small to detect differences in subcategories of adverse
neonatal outcome, but no obvious differences between the
two groups were observed.
Table 1 Baseline characteristics of the total cohort in prenatally detected and nondetected SGA infants
Characteristic SGA detected
prenatally (n ¼ 163)
SGA not detected
prenatally (n ¼ 555)
p-Value Standardized
difference (%)
Maternal characteristicsa
Age (y, mean  SD) 29.3  5.7 30.1  5.8 0.11 14.6
BMI (median, range)a 22.5 (16–44) 22.2 (16–43) 0.69 2.6
Primiparity (%) 90 (55) 237 (43) < 0.01 25.1
Smoking (%) 53 (33) 82 (15) < 0.01 37.8
Gestational hypertension (%) 9 (5.5) 26 (4.7) 0.67 3.7
Fetal characteristics
Birth weight percentile (median, range) 1.6 (0–9.9) 5.1 (0–10) < 0.01 63.9
Birth weight < p2.3 (%) 83 (51) 118 (21) < 0.01 59.1
Birth weight < p5 (%) 124 (76) 270 (49) < 0.01 64.1
Abbreviations: BMI, body mass index; SD, standard deviation; SGA, small for gestational age (birth weight < p10).
aThe body mass index is the weight in kilograms divided by the square of the height in meters.
Fig. 1 Eligibility and exclusion of pregnancies.
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In the complete (unmatched) cohort (n ¼ 718), perinatal
mortality did not occur among 163 prenatally detected SGA
infants and in 1.3% (7/555) of the nonprenatally detected
SGA infants. These comprised six fetal deaths before the
onset of labor (detected at 374/7, 381/7, 391/7, 392/7, 402/7,
and 405/7 weeks GA), and one fetal death during labor
(406/7 weeks GA).
To show a statistical signiﬁcant difference (with α 0.05) in
composite adverse neonatal outcome with 80% power, a
sample size of 2,727 per group is needed. To showa statistical
signiﬁcant difference in perinatal death, a sample size of 422
per group is needed.
Labor was more often induced if SGAwas detected prena-
tally (57 vs. 9% of women, OR 14, 95% CI 7.4–26). There were
Table 2 Baseline characteristics of matched cohort in prenatally detected and nondetected SGA infants
Characteristic SGA detected
prenatally (n ¼ 163)
SGA not detected
prenatally (n ¼ 163)
p-Value Standardized
difference (%)
Maternal characteristicsa
Age (y, mean  SD) 29.3  5.7 29.3  6.1 0.99 0.1
BMI (median, range)a 22.9 (16–44) 22.8 (16–43) 0.45 7.9
Primiparity (%) 90 (55) 91 (56) 0.91 1.2
Smoking (%) 53 (33) 52 (32) 0.91 1.3
Gestational hypertension (%) 9 (5.5) 9 (5.5) 1.00 0.0
Neonatal outcome
Birth weight percentile (median, range) 1.6 (0–9.9) 1.9 (0–10) 0.68 4.5
Birth weight < p2.3 (%) 83 (51) 83 (51) 1.00 0.0
Birth weight < p5 (%) 124 (76) 122 (75) 0.80 2.9
Abbreviations: BMI, body mass index; SD, standard deviation; SGA, small for gestational age (birth weight < p10).
aThe body mass index is the weight in kilograms divided by the square of the height in meters.
Fig. 2 Distribution of propensity scores before and after matching. Pregnancies were stratiﬁed by prenatal small for gestational age detection.
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more cesarean sections performed in the prenatally detected
SGA group (20%) than in the nonprenatally detected SGA
group (8%), OR 2.9, 95% CI 1.5–5.8, mostly all for suspected
fetal distress. Failure to progresswas never the indication for a
cesarean section in labor in the prenatally detected SGA
group and once (0.6%) in the nonprenatally detected SGA
group.
The rate of vaginal instrumental delivery in the prenatally
detected SGA group (6%) was lower than in the nonprenatally
detected SGA group (12%) although this did not reach statis-
tical signiﬁcance (OR 0.50, 95% CI 0.22–1.1, p ¼ 0.09). There
were no signiﬁcant differences in indication for vaginal
instrumental delivery between the prenatally detected SGA
and nonprenatally detected SGA group (►Table 3). On aver-
age, prenatally detected SGA neonates were born 7.4 days
earlier than nonprenatally detected SGA neonates (385/7 vs.
395/7 weeks, 95% CI 9.3 to 5.6, p < 0.001), and prenatally
detected SGA neonates weighed on average 223 g less than
nonprenatally detected SGA neonates (median 2,410 vs.
2,640 g, 95% CI 293 to 153, p < 0.001).
Sensitivity Analyses
Both the percentages and p values of the multivariable
logistic regression analysis on the complete cohort
(n ¼ 718) (Appendix 1), and the analyses on the nonimputed
cohort after propensity score matching (Appendices 2 and 3),
were comparable to the results of the propensity score
analysis.
Table 3 Propensity score matching (1:1) of the association between prenatal SGA (birth weight < p 10) detection and adverse
pregnancy outcome and perinatal interventions
Outcome SGA detected
prenatally
(n ¼ 163)
SGA not detected
prenatally
(n ¼ 163)
p-Value OR 95% CI
Delivery, n (%)
Induction of labor 93 (57) 14 (9) < 0.001 13.95 7.43–26.19
Instrumental delivery 43 (26) 32 (20) 0.15 1.46 0.87–2.5
Cesarean section 33 (20) 13 (8) 0.02 2.93 1.48–5.80
Primary cesarean section 7 (4.3) 1 (0.6) 0.07 7.27 0.88–59.77
Cesarean section in labor 26 (16) 12 (7.4) 0.02 2.39 1.16–4.92
Failure to progress 0 (0) 1 (0.6) 0.996 not calculable
Fetal distress 26 (16) 11 (6.7) 0.03 2.27 1.07–4.83
Vaginal instrumental delivery 10 (6.1) 19 (12) 0.09 0.50 0.22–1.10
Failure to progress 2 (1.2) 7 (4.3) 0.11 0.28 0.06–1.35
Fetal distress 8 (4.9) 12 (7.4) 0.36 0.65 0.26–1.63
Neonatal outcome, n (%)
Mean gestational age at birth
(d, mean  SD)
270.6  9.6 278.0  6.6 < 0.001 7.4a 9.3 to 5.6
Birth weight (g; median, IQR) 2,410 (1,420–3,080) 2,640 (1,765–3,250) < 0.001 223a 293 to 153
Composite adverse neonatal outcome 9 (5.5) 12 (7.4) 0.50 0.74 0.30–1.80
Perinatal mortality 0 (0.0) 3 (1.8) 0.996 not calculable
5 min Apgar score < 7 4 (2.5) 4 (2.5) 1.00 1.00 0.25–4.07
Neonatal complicationsb 3 (1.8) 4 (2.5) 0.70 0.75 0.16–3.38
Asphyxia 1 (0.6) 0 (0.0) n.c.
IRDS 0 (0.0) 0 (0.0) n.c.
Meconium aspiration 0 (0.0) 2 (1.2) n.c.
Pneumothorax 1 (0.6) 3 (1.9) n.c.
NEC 1 (0.6) 0 (0.0) n.c.
Convulsions 1 (0.6) 0 (0.0) n.c.
Sepsis 0 (0.0) 0 (0.0) n.c.
Meningitis 0 (0.0) 0 (0.0) n.c.
Abbreviations: CI, conﬁdence interval; IQR, interquartile ratio; IRDS, infant respiratory distress syndrome; n.c., not calculated; NEC, necrotizing
enterocolitis; OR, odds ratio; SD, standard deviation; SGA, small for gestational age (birth weight < 10th percentile).
aMean difference and 95% CI.
bNumber of infants with neonatal complications, some infants have more than one complication.
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Discussion
This study conﬁrms that in a system without routine third
trimester growth screening ultrasounds, the largemajority of
women with a term-SGA pregnancy remain undetected until
birth. However, severe SGA was more likely to be detected
prenatally than mild SGA, although even in women with a
child below the 2.3rd percentile the diagnosis fetal growth
restriction was missed in 60%.12,13 Obviously, prenatal SGA
detection is associated with induction of labor and cesarean
section.12,13Womenwith prenatally detected SGA gave birth
more than a week earlier. Birth weight of prenatally detected
SGA infants was more than 200 g lower. In the whole non-
prenatally detected SGA group there were seven fetal deaths
(of which three in the propensity score matched group),
while none of the prenatally detected SGA infants died. The
composite poor neonatal outcome occurred less often in the
prenatally detected SGA group, although the difference was
not statistically signiﬁcant.
Strengths
Our study has several strengths. First, we assessed outcomes
of prenatally detected SGA and nonprenatally detected SGA
pregnancies balanced for propensity score, and therefore
balanced for the covariates used to estimate the propensity
score. These balanced covariates will no longer confound the
relation between prenatal SGA detection and the outcome.
Therefore, in contrast to two previous studies on the same
subject where propensity score matching has not been
performed to create comparable groups, the estimation will
be theoretically unbiased, or at least less biasedness will have
occurred.12,13
Second, we incorporated severity of SGA into the model as
a continuous variable (birth weight percentile), instead of
adjusting for birth weight and GA at delivery. Failure to do so
in other studies might have biased the association between
SGA detection and perinatal outcome.12,13 The reliability of
our results is further supported by the completeness and
accuracy of prenatal and postnatal data of mother and child.
Complete datawere available for all pregnancies because data
were extracted from the original patient ﬁles and comple-
mented with use of the PRN registry if needed.
Limitations
The ﬁrst limitation of this study is its sample size combined
with the low incidence of adverse pregnancy outcome,
speciﬁcally regarding perinatal mortality. Given the low
incidence of adverse pregnancy outcome at term, a very
large sample is required to show a difference. Although,
this study does not have enough power to detect a statisti-
cally signiﬁcant difference in rare adverse neonatal out-
comes, to our knowledge this is the largest study that
compared outcome of prenatally detected SGA with non-
prenatally detected SGA infants. The precision of the results
is quite limited due to the sample size, but the propensity
score matching has resolved most of the bias that would be
present in larger samples that are unmatched for relevant
baseline variables.
Second, there is a possible a priori risk selection of
prenatally detected SGA pregnancies. Women with an in-
creased a priori risk of adverse pregnancy outcome receive
regular ultrasound growth assessment. As a result, SGA
infants in this high-risk population will likely be detected
prenatally, whereas SGA is more likely to remain undetected
until birth in low-risk pregnancies. We expect to have mini-
mized this effect by the propensity score matching of the
potential confounding maternal characteristics that were
available and severity of SGA. However, we cannot fully
exclude the possibility of residual confounding.
Third, in case of fetal death, there was no certainty about
the moment of demise. This might have led to an overestima-
tion of SGA severity in these infants. We expect this overesti-
mation to be limited because—according to the Dutch
protocol—all pregnant women undergo weekly checkups
including Doppler auscultation of the fetal heart rate.
Fourth, unfortunately we did not know for all pregnancies
if third trimester growth ultrasound had been performed.
Therefore, we cannot report sensitivity and speciﬁcity of
growth ultrasounds. The false reassurance about fetal growth
in 19% of women that were referred for suspicion of SGA
makes us suspect that the sensitivity of prenatal ultrasound
especially in high-risk pregnancies can be improved. Due to
propensity score matching we could not take the majority of
nonprenatally detected SGA infants into account in the
analyses. We ﬁrst performed one-to-two matching to limit
the data loss but the matching process did not yield compa-
rable groups, mainly due to considerable difference in SGA
severity between prenatally detected SGA and nonprenatally
detected SGA infants. We have chosen one-to-one matching
to warrant the optimal comparability of prenatally detected
SGA and nonprenatally detected SGA infants, and also to
obtain more reliable results. Additional sensitivity analyses
on the entire imputed sample of 718 SGA neonates and on the
original, nonimputed, cohort after propensity score matching
showed results similar to the propensity-score analysis.
Considerations about Results
This study conﬁrms the low prenatal detection rates of
SGA.12,13,27 The majority of pregnancies with an SGA infant
remained undetected until birth, severe SGA is more likely to
be detected prenatally. This is in concordance with literature
which showed that the results of ultrasounds are unreliable to
estimate the fetal weight < p10 correctly.28,29 Previous stud-
ies have also shown high-false positive rates (30%) of prenatal
SGA detection.6 Since we only assessed infants with a birth
weight below the 10th percentile for GA, we could not rule on
speciﬁcity of prenatal growth ultrasound.
Maternal smoking was more prevalent in the prenatally
detected SGA group. This might be caused by awareness of
caregivers for the potentially adverse effect of maternal
smoking on fetal growth.6,30–33 The statistically signiﬁcant
lower GA at birth and lower birth weight of the infants in the
prenatally detected SGA group can be explained by the higher
incidence of obstetrical interventions in this group.12,13,28,33
The study by Verlijsdonk et al concluded that suspicion of
SGAwas associated with a more active management of labor
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and delivery, resulting in a better neonatal outcome at birth.13
We observed a similar trend as Verlijsdonk et al that prena-
tally detected SGA fetuses have a better perinatal outcome.
Combining the cohort of Verlijsdonk et al with our matched
cohort results in 0.6% (2/321) perinatal deaths among prena-
tally detected SGA infants and 2.3% (10/435) perinatal deaths
among nonprenatally detected SGA infants (OR 0.27, 95% CI
0.06–1.22, p ¼ 0.09). Suggesting improved perinatal outcome
of prenatally detected SGA infants compared with nonpre-
natally detected SGA infants.
Our study also conﬁrms the more active management of
labor among prenatally detected SGA infants. Increased in-
duction of labor in the prenatally detected SGA group did not
lead to higher rates of cesarean sections for failure to progress
(stages I and II), but it led to more cesarean sections for
suspected fetal distress, and less vaginal instrumental deliv-
eries. The increased rate of cesarean sections and decreased
rate of vaginal instrumental deliveries in prenatally detected
SGA pregnancies might be caused by earlier intervention in
case of suspected fetal distress—in view of the suspected SGA
—or possible preference of the caregiver not to perform
vaginal instrumental delivery if severe SGA is suspected.
This assumption is supported by the trend toward more
vaginal instrumental deliveries in the nonprenatally detected
SGA group.
Choosing the 10th percentile as SGA cut off causes inclu-
sion of a relatively large group of low-risk constitutionally
small infants into the study population, by deﬁnition 10% of
the population. Previous research has shown an association
between the severity of SGA and perinatal outcome.34A study
by Unterschneider et al showed that an estimated fetal
weight < p3 is strongly and consistently associated with
adverse perinatal outcome.35 Our population consisted of a
heterogeneous group of SGA infants. However, after propen-
sity scorematching, themedian birthweight percentileswere
1.6 and 1.9 among prenatally detected SGA and nonprenatally
detected SGA infants, indicating selection of mainly infants
who are severely SGA.
Although, this study was underpowered to show a differ-
ence in the incidence of perinatal mortality between non-
prenatally detected SGA and prenatally detected SGA infants,
there were no perinatal deaths among prenatally detected
SGA infants and seven among nonprenatally detected SGA
infants in the complete cohort of 718 infants.
In the propensity-matched cohort, these numbers were
zero and three, respectively. Six out of seven fetal deaths
occurred before the onset of labor, versus one fetal death
during labor. Considering the fact that death only occurred in
SGA infants that were not detected prenatally, in which SGA
was relatively milder than in the prenatally detected SGA
group, it is not unlikely that death could have been avoided
with fetal monitoring and induced labor if SGA had been
detected before birth. However, we are not sure how prenatal
SGA detection can be improved.
The low prenatal SGA detection rate in our study has
several potential causes. First, the absence of third trimester
ultrasound growth assessment as part of standard pregnancy
care might play a role. Although, it seems logical that third
trimester ultrasound as part of standard pregnancy care
improves SGA detection rates, this has to our knowledge
not been proven. Unfortunately our data do not allow quan-
tiﬁcation of how many women underwent third trimester
ultrasound growth assessment.
Second, inaccuracy of ultrasound growth assessment in
the third trimester might play a role. Prenatal ultrasound
growth assessment is usually performed prior to 360/7 weeks
gestation because diagnostic accuracy decreaseswith advanc-
ing GA.36
A third possibility is that growth impairment starts after a
reassuring third trimester growth ultrasound has been per-
formed. We do not know if severe SGA always originates
gradually and that poor detection is caused by inaccurate
ultrasound measurements, or that growth of properly grown
infants slows and comes to a halt after a—proper—ultrasound
measurement in the third trimester.
Implications for Clinical Practice
This study shows that in the Dutch care system term SGA
often remains undetected until birth and that prenatal SGA
detection might prevent neonatal deaths. Caregivers
and especially ultrasonographers should be aware of this
to avoid as much as possible false reassurance of fetal
growth.
If in any doubt about fetal growth, women should be
followed up with umbilical artery measurements.37 This
allows for intervention if fetal condition is compromised
and might prevent unnecessary interventions on constitu-
tionally small infants that are not growth restricted. Also, it is
rational to choose induction after 380/7 weeks GA in case of
suspected SGA to prevent possible neonatal morbidity and
stillbirth.6,38
Women should be informed that—in case of suspected SGA
at term—the risk of adverse pregnancy outcome is very small,
but follow-up might be beneﬁcial for them. The potential
beneﬁt for mother and child clearly outweighs the relatively
light burden of follow-up ultrasounds.
Conﬁrmation of SGA suspicion allows intervention, but
caregivers should realize that intervention does not always
improve outcome and does always bear risks for mother and
child. Therefore, potential harm tomother and child in case of
intervention should be weighed against the potential risk of
expectant management on the other hand.
Note
The registry data are anonymous; therefore no ethical
approval was needed. The Netherlands Perinatal Registry
has given permission for the analysis of its data, approval
number 11.42.
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Appendix 2 Baseline characteristics of the matched original cohort. Pregnancies are stratiﬁed by prenatal SGA detection
Characteristic SGA detected
prenatally (n ¼ 163)
SGA not detected
prenatally (n ¼ 163)
p-Value Standardized
difference (%)
Maternal characteristicsa
Age (y, mean  SD) 29.3  5.7 29.0  5.9 0.71 4.2
Maternal BMI (median, range)a 22.5 (16–44) 22.4 (16–40) 0.51 9.5
Primiparity (%) 90 (55) 90 (55) 1.00 0.0
Smoking (%) 53 (32) 50 (31) 0.72 3.9
Gestational hypertension (%) 9 (5.5) 8 (4.9) 0.80 2.7
Neonatal outcome
Birth weight percentile (median, range) 1.6 (0–9.9) 1.9 (0–9.9) 0.82 2.5
Birth weight < p2.3 (%) 83 (51) 84 (52) 0.91 1.2
Birth weight < p5 (%) 124 (76) 123 (76) 0.90 1.5
Abbreviations: BMI, body mass index; SD, standard deviation; SGA, small for gestational age (birth weight < 10th percentile).
aThe body mass index is the weight in kilograms divided by the square of the height in meters.
Appendix 1 Multivariable association between prenatal SGA (birth weight < 10th percentile) detection and adverse pregnancy
outcome and perinatal interventions in the original dataset
Outcome SGA detected
prenatally
(n ¼ 163)
SGA not detected
prenatally (n ¼ 555)
p-Value OR 95% CI
Delivery, n (%)
Induction of labor 93 (57) 50 (9) 0.00 16.61 10.15–27.17
Instrumental delivery 43 (26) 82 (15) 0.07 1.56 0.97–2.50
Cesarean section 33 (20) 40 (7.3) 0.00 2.68 1.54–4.64
Primary cesarean section 7 (4.3) 4 (0.7) 0.00 8.34 2.07–33.66
Cesarean section in labor 26 (16) 36 (6.5) 0.02 2.06 1.14–3.74
Vaginal instrumental delivery 10 (6.1) 42 (7.6) 0.12 0.54 0.25–1.17
Neonatal outcome, n (%)
Mean gestational age at birth
(d, mean  SD)
271 (9.6) 277 (6.0) < 0.001 6.5a 7.9 to 5.2
Birth weight (g; median, IQR) 2,410 (1,420–3,080) 2,770 (1,765–3,250) < 0.001 343a 392 to 294
Composite adverse neonatal outcome 9 (5.5) 27 (4.9) 0.36 0.67 0.29–1.57
Perinatal mortality 0 (0) 7 (1.3) 0.995 not calculable
5 min Apgar score < 7 4 (2.5) 9 (1.6) 0.96 1.04 0.29–3.74
Neonatal complicationsb 3 (1.8) 10 (1.8) 0.21 0.40 0.09–1.67
Asphyxia 1 (0.6) 3 (0.5) n.c.
IRDS 0 (0) 1 (0.2) n.c.
Meconium aspiration 0 (0) 4 (0.7) n.c.
Pneumothorax 1 (0.6) 4 (0.7) n.c.
NEC 1 (0.6) 0 (0) n.c.
Convulsions 1 (0.6) 1 (0.2) n.c.
Sepsis 0 (0) 0 (0) n.c.
Meningitis 0 (0) 0 (0) n.c.
Abbreviations: CI, conﬁdence interval; IRDS, infant respiratory distress syndrome; n.c., not calculated; NEC, necrotizing enterocolitis; OR, odds ratio;
SD, standard deviation; SGA, small for gestational age (birth weight < 10th percentile).
aMean difference and 95% CI.
bNumber of infants with neonatal complications, some infants have more than one complication.
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Appendix 3 Propensity score analyses of prenatal SGA (birth weight < p10) detection as predictor of adverse pregnancy outcome
and perinatal interventions after 1:1 propensity score matching in the original dataset
Outcome SGA detected
prenatally (n ¼ 163)
SGA not detected
prenatally (n ¼ 163)
p-Value OR 95% CI
Delivery, n (%)
Induction of labor 93 (58) 16 (9.9) < 0.001 12.04 6.59–21.99
Instrumental delivery 43 (26) 28 (17) 0.045 1.73 1.01–2.95
Cesarean section 33 (20) 11 (6.7) 0.002 3.51 1.71–7.22
Primary cesarean section 7 (4.3) 0 (0.0) inf.
Cesarean section in labor 26 (16) 11 (6.7) 0.01 2.62 1.25–5.51
Vaginal instrumental delivery 10 (6.1) 17 (10) 0.16 0.56 0.25–1.27
Neonatal outcome, n (%)
Mean gestational age at birth
(d, mean  SD)
270.6  9.6 278.1  6.8 < 0.001 7.5a 9.3 to 5.7
Birth weight (g; median, range) 2,410 (1,420–3,080) 2,650 (1,765–3,090) < 0.001 225a 295 to 156
Composite adverse neonatal outcome 9 (5.5) 13 (8.0) 0.38 0.67 0.28–1.62
Death 0 (0.0) 3 (1.8) 0.996 not calculable
5 min Apgar score < 7 4 (2.5) 4 (2.5) 1.00 1.00 0.25–4.07
Neonatal complicationsb 3 (1.8) 5 (3.1) 0.48 0.59 0.14–2.52
Asphyxia 1 (0.6) 0 (0.0) n.c.
IRDS 0 (0.0) 0 (0.0) n.c.
Meconium aspiration 0 (0.0) 3 (1.9) n.c.
Pneumothorax 1 (0.6) 4 (2.5) n.c.
NEC 1 (0.6) 0 (0.0) n.c.
Convulsions 1 (0.6) 0 (0.0) n.c.
Sepsis 0 (0.0) 0 (0.0) n.c.
Meningitis 0 (0.0) 0 (0.0) n.c.
Abbreviations: CI, conﬁdence interval; OR, odds ratio; inf., inﬁnite; IRDS, infant respiratory distress syndrome; n.c., not calculated; NEC, necrotizing
enterocolitis; SD, standard deviation.
aMean difference and 95% CI.
bNumber of infants with neonatal complications, some infants have more than one complication.
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